Publications (24 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.* Ozawa Y et al. (2021) Changes in serum complements and their regulators in generalized myasthenia gravis. Euro. J. Neuro. 28:314-322.
* Andersone BJ (2020) Lymphatic Filariasis: Host and parasite factors and the pathogenesis of systemic adverse events following treatment. Washington University in St. Louis Electronic Theses and Dissertations. 2160.
* Chaika K et al. (2019) The status of the C3 fnd C4 fractions of the complement system in children with Henoch-Schelan purpura. Pediatr Pol. 94 (4): 229-234.
* Andersen BJ et al. (2019) Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis. PLoS Negl Trop Dis. 13(9):e0007697.
* Okuzaki D et al. (2017) FCN1 (M-fcolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease. Sci Rep. 7(1):11334.
* Hoefman S et al. (2018) Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies. United States Patent 10118967
* Yurova BA et al. (2017) Changes in the complement system in membranoproliferative glomerulonephritis. https://doi.org/10.17116/terarkh201789669-77.
* Wasiak S et al. (2017) Downregulation of the complement cascade in vitro, in mice and in patients with cardiovascular disease by the BET protein inhibitor apabetalone (RVX-208). J. of Cardiovasc. Trans. Res. 10:337-347.
* Mizuno M et al. (2017) High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients. PLoS One. 12(1):e0169111
* Yadav AP et al. (2015) Activation of Complement System during Ship Voyage and Winter-over Expedition in Antarctica. J Marine Sci Res Dev. 5:3.
* Sei Y et al. (2015) Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy. Mol Immunol. 65(2):302-9
* Menzhinskaya IV et al. (2015) Incidence of Autoantibodies to C1Q Complement Component in Women with Miscarriages and Autoantibodies to Phospholipids and Chorionic Gonadotropin. Bull Exp Biol Med. 160(2):260-3.
* Hoefman S et al. (2015) Treatment of il-6r related diseases. Patent application: US20190119392A1.
* Ajona D et al. (2015) Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer. PLoS One. 10(3):e0119878.
* Sudzius G et al. (2014) Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjogren's syndrome? Rheumatol Int. 34(2):235-41.
* Gawad ERA (2014) Role of Anti-nucleosome Antibodies in the Diagnosis of Systemic Lupus Erythematosus and as A Marker for Lupus Nephropathy. THE EGYPTIAN JOURNAL OF IMMUNOLOGY 21(1):57-65
* EI-Gendy NA et al. (2014) Diagnosis of spontaneous bacterial peritonitis. The Egyptian Journal of Internal Medicine 26(2):53-59
* Dowling P et al. (2014) Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease. BMC Genomics. 2014 Oct 17;15:904. doi: 10.1186/1471-2164-15-904
* Koehler EM (2013) Non-alcoholic fatty liver disease. From patient to population. Erasmus University Medical Center Rotterdam. Dissertation.
* Guichelaar MMJ et al. (2013) Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. Obesity 21(9):1935-1941
* Koehler E et al. (2012) Growth hormone, dehydroepiandrosterone and adiponectin levels in non?alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. Liver Int. 32(2):279-86
* Charlton MR (2012) Serum Biomarkers For Early Detection Of Acute Cellular Rejection. Patent application number: 20120014949 A1
* Massoud O et al. (2011) Noninvasive Diagnosis of Acute Cellular Rejection in Liver Transplant Recipients: A Proteomic Signature Validated by Enzyme-Linked Immunosorbent Assay. Liver Transpl. 17(6):723-32.
* Alam HB and Li Y (2011) Biomarkers of hemorrhagic shock. Patent application number: 20130149713
